Home
About
Directors and Management
Careers
Corporate Governance
Board Charter
Code of Conduct
Audit Committee Charter
Nomination and Remuneration Committee Charter
Continuous Disclosure Policy
Share Trading Policy
Risk Management Policy
Social Media Policy
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
Whistleblower Policy
Investors
Public Disclosure Policy
ASX Announcements
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Contact
Shop évolis®
✕
2021
Home
2021
January 31, 2022
Published by
Lindsay Gordon
on
January 31, 2022
Categories
Second Supply Agreement for Anagenics’ FGF5 Inhibitors
December 16, 2021
Published by
Lindsay Gordon
on
December 16, 2021
Categories
Change of Company Name
December 15, 2021
Published by
ritzdigi
on
December 15, 2021
Categories
Annual General Meeting – CEO Presentation
December 15, 2021
Published by
ritzdigi
on
December 15, 2021
Categories
Release of Shares from Voluntary Escrow
December 15, 2021
Published by
ritzdigi
on
December 15, 2021
Categories
Results of Annual General Meeting
November 11, 2021
Published by
Lindsay Gordon
on
November 11, 2021
Categories
Cellmid receives R&D tax credit
November 10, 2021
Published by
Lindsay Gordon
on
November 10, 2021
Categories
Proposed issue of securities – CDY
November 10, 2021
Published by
Lindsay Gordon
on
November 10, 2021
Categories
Letter to Shareholders – Notice of Annual General Meeting
November 10, 2021
Published by
Lindsay Gordon
on
November 10, 2021
Categories
Notice of Annual General Meeting – Proxy Form
1
2
3
4
5
6
7
Next page
Shop évolis®
